FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

CBER Plans to Normalize Operations in 2023

[ Price : $8.95]

CBER updates its prioritization schedule for the remainder of 2022 to account for Covid-19-related work, while it plans to return ...

LabCorp Gains EUA for Covid Lineage Test

[ Price : $8.95]

FDA grants an emergency use authorization for Laboratory Corp. of Americas VirSeq SARS-CoV-2 NGS Test on the PacBio Sequel II sequ...

Green Pharma Recalls SnoreStop Lot

[ Price : $8.95]

Green Pharmaceuticals recalls one lot of its SnoreStop NasoSpray after FDA testing found the product contained a microbial contami...

FDA Clears 2 Thermo Scientific Tests

[ Price : $8.95]

FDA clears Thermo Scientific 510(k)s for its EliA RNA Pol III and EliA Rib-P tests for aiding in the diagnosis of systemic scleros...

DoJ Defends 'Fraud-on-FDA' in 1 Specific Case

[ Price : $8.95]

Sidley attorneys say the Justice Department voiced strong support for a fraud-on-FDA theory of liability in a case involving blood...

Some Mole Products Can Injure, Scar: FDA

[ Price : $8.95]

FDA cautions consumers not to use products marketed as mole or skin tag removers.

Foundation Medicine Companion Diagnostic Approved

[ Price : $8.95]

FDA approves a Foundation Medicine PMA for its FoundationOne CDx to be used as a companion diagnostic for the two approved indicat...

Concerns on Drug Quality Metrics Proposal Aired

[ Price : $8.95]

Four additional stakeholders raise concerns about the FDA quality metrics proposal.

5 Observations on BPI Labs FDA-483

[ Price : $8.95]

FDA releases the FDA-483 with five observations issued following a 2021 inspection at Largo, FL-based BPI Labs.

Cruz, Others Question FDA on Covid-19 Vaccines for Babies

[ Price : $8.95]

Some 18 members of Congress ask FDA 19 questions about Covid-19 vaccine safety in children under age 5.